The U.S. Justice Department sought court permission to participate in settlement negotiations aimed at resolving lawsuits by state and local governments against opioid manufacturers and distributors.
New Hampshire sued OxyContin maker Purdue Pharma over accusations of deceptive marketing practices that have helped fuel a national opioid addiction epidemic.
Maryland lawmakers have passed a first-in-the-nation measure that lets the state attorney general sue generic drug makers that sharply raise prices in a move aimed at fighting “price gouging.”
Theranos reportedly failed to notify patients in Arizona about potentially deficient diabetes tests.
Connecticut and 19 other states filed a lawsuit against Mylan, Teva Pharmaceuticals and four other generic drug makers saying they entered into illegal conspiracies that raised prices on two common generic drugs, the New York state attorney general’s office said in a statement.
Valeant Pharmaceuticals is under fire over a 2,700 percent price hike of a drug used to treat lead poisoning.
Massachusetts’ attorney general is studying whether the prices of Gilead Sciences Inc’s blockbuster treatments for hepatitis C violate state law, according to a letter the prosecutor sent to the California drugmaker. The letter from Attorney General Maura Healey to Gilead Chief Executive Officer John Martin, dated January 22, asked the biotechnology company to reconsider its […]